Skip to content

A Feasibility Study to Collect Data in Patients With Haemophilia

A Multi Centre Study With no Treatment, Designed to Gain Information About the Haemophilia Patient Population

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00798499
Enrollment
50
Registered
2008-11-26
Start date
2008-12-31
Completion date
2009-06-30
Last updated
2009-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemophilia

Keywords

haemophilia, patients with haemophilia

Brief summary

The purpose of this study is to collect reference data in patients with haemophilia. The study will also collect and store blood samples for potential future exploratory research in the disease area.

Interventions

OTHERLaboratory variables

1 visit

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Provision of written informed consent * Patients with haemophilia, all severities * At least 18 years old.

Exclusion criteria

* No

Design outcomes

Primary

MeasureTime frame
Laboratory variables related to coagulation, SAEs in connection to blood sampling procedures will be collected, non-serious AEs will not be recordedThe variables will be measured at first visit.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026